GLAXO
Invest Now
GlaxoSmithKline Pharmaceuticals Share Price
₹2,411.80 +42.15 (1.78%)
23 Nov, 2024 00:09
Start SIP in GLAXO
Start SIPPerformance
- Low
- ₹2,350
- High
- ₹2,440
- 52 Week Low
- ₹1,617
- 52 Week High
- ₹3,088
- Open Price₹2,389
- Previous Close₹2,370
- Volume288,891
Investment Returns
- Over 1 Month -8.77%
- Over 3 Month -21.22%
- Over 6 Month + 2.88%
- Over 1 Year + 45.28%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 60.5
- PEG Ratio
- 14.4
- Market Cap Cr
- 40,857
- P/B Ratio
- 23
- Average True Range
- 86.51
- EPS
- 47.33
- Dividend Yield
- 1.8
- MACD Signal
- -57.95
- RSI
- 35.07
- MFI
- 40.78
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,411.80
+
42.15
(1.78%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹2,535.60
- 50 Day
- ₹2,623.09
- 100 Day
- ₹2,612.70
- 200 Day
- ₹2,446.75
Resistance and Support
2400.57
- R3 2,541.03
- R2 2,490.47
- R1 2,451.13
- S1 2,361.23
- S2 2,310.67
- S3 2,271.33
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,411 As on 22 November, 2024 | 23:55
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹40857.3 Cr As on 22 November, 2024 | 23:55
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 60.5 As on 22 November, 2024 | 23:55
The PB ratio of GlaxoSmithKline Pharmaceuticals is 23 As on 22 November, 2024 | 23:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.